DMD Noab BioDiscoveries - Shaping Drug Discovery

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


0090-9556/03/3106-697-700$20.00
DMD 31:697-700, 2003

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sheng, J. J.
Right arrow Articles by Duffel, M. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sheng, J. J.
Right arrow Articles by Duffel, M. W.
SHORT COMMUNICATION

ENANTIOSELECTIVITY OF HUMAN HYDROXYSTEROID SULFOTRANSFERASE ST2A3 WITH NAPHTHYL-1-ETHANOLS

(Received December 16, 2002; accepted March 13, 2003)


    Abstract
 Top
 Abstract
 Materials and Methods
 Results and Discussion
 References
 
Hydroxysteroid (alcohol) sulfotransferases catalyze the sulfation of several endogenous steroids and many hydrophobic xenobiotic alcohols. The substrate stereoselectivities of sulfotransferases may be critically important in determining their overall roles in metabolism of drugs, carcinogens, and other xenobiotics. In the present work, stereoselectivity of the human hydroxysteroid sulfotransferase ST2A3 (also variously named as SULT2A1 or human DHEA-ST) was examined through analysis of its catalytic activities with the enantiomers of 1-naphthyl-1-ethanol and 2-naphthyl-1-ethanol. The kcat/Km value for sulfation of the R-(+)-enantiomer of 1-naphthyl-1-ethanol catalyzed by ST2A3 was 3.3 min-1mM-1, whereas the S-(-)-enantiomer was not a substrate for the enzyme. S-(-)-1-naphthyl-1-ethanol did however interact with ST2A3 as an inhibitor of the sulfation of dehydroepiandrosterone. This substrate stereospecificity was not present with the enantiomers of 2-naphthyl-1-ethanol, since both were substrates for the enzyme. Such differences between the sulfation of 1- and 2-naphthyl-1-ethanol are consistent with the importance of steric interactions between the ethanol group and a hydrogen atom at the peri-position (C8) on the naphthyl ring in 1-naphthyl-1-ethanol that combine with the topology of the enzyme's active site to determine stereospecificity.


Sulfate conjugation is an important pathway in the biotransformation of many endogenous and exogenous compounds. The mammalian cytosolic enzymes that catalyze sulfation constitute a superfamily of sulfotransferases that use a broad array of hormones, neurotransmitters, drugs, and carcinogens as substrates (Jakoby et al., 1980Go; Jakoby and Ziegler, 1990Go; Duffel, 1997Go; Falany, 1997Go; Weinshilboum et al., 1997Go; Nagata and Yamazoe, 2000Go; Duffel et al., 2001Go; Glatt et al., 2001Go). The reactions involve the transfer of a sulfuryl group from 3'-phosphoadenosine 5'-phosphosulfate (PAPS1) to a hydroxyl or amino functional group of an acceptor molecule, and the products are adenosine 3', 5'-diphosphate (PAP), and a sulfuric acid ester, respectively.

Hydroxysteroid (alcohol) sulfotransferases, enzymes constituting a subfamily of the mammalian cytosolic sulfotransferases, catalyze the sulfation of a wide variety of hydroxylated endobiotic and xenobiotic compounds (Lyon et al., 1981Go; Ogura et al., 1990Go; Falany et al., 1994Go; Glatt, 1997Go; Kudlacek et al., 1997Go; Shibutani et al., 1998Go; Lewis et al., 2000Go). In addition to hydroxysteroids, the xenobiotic substrates of hydroxysteroid sulfotransferases include many benzylic alcohols derived from alkyl-substituted polycyclic aromatic hydrocarbons, environmental contaminants known to induce mutations and tumors in both experimental animals and humans (Watabe et al., 1982Go; Surh et al., 1990Go; Miller and Surh, 1994Go; Yamazoe et al., 1999Go). Hydroxysteroid (alcohol) sulfotransferase was first purified to homogeneity from rat liver by Jakoby and coworkers (Lyon and Jakoby, 1980Go). To date, the cDNAs of hydroxysteroid sulfotransferases have been identified from both human and rodent species (Ogura et al., 1989Go; Kong et al., 1992Go; Comer et al., 1993Go; Otterness and Weinshilboum, 1994Go; Sakakibara et al., 1998Go; Chang et al., 2001Go), and the crystal structure of a human hydroxysteroid sulfotransferase has been determined (Pedersen et al., 2000Go; Rehse et al., 2002Go).

The influence of structural characteristics of various substrates on the catalytic efficiency of a hydroxysteroid sulfotransferase from rat liver has been studied previously (Chen et al., 1996Go; Banoglu and Duffel, 1997Go, 1999Go; Sheng and Duffel, 2001Go). One of these important characteristics is the stereochemistry of the molecule that serves as the sulfuryl acceptor. This substrate-stereoselectivity has been found in the sulfation of several model chiral secondary alcohols catalyzed by the rat hepatic hydroxysteroid sulfotransferase (Chen et al., 1996Go; Banoglu and Duffel, 1997Go, 1999Go). We now report on the stereoselectivity of the human hydroxysteroid sulfotransferase, ST2A3, using the enantiomers of 1- and 2-naphthyl-1-ethanols (Fig. 1) as model substrates.



View larger version (28K):
[in this window]
[in a new window]
 
FIG. 1. Structural representations of 1- and 2-naphthyl-1-ethanols that show the peri-interaction (peri-hydrogen in boldface type on carbon-8) that restricts rotation of the benzylic carbon-aromatic carbon bond in the 1-isomer and the full rotation of the analogous carbon-carbon bond that is allowed in the 2-isomer.

 


    Materials and Methods
 Top
 Abstract
 Materials and Methods
 Results and Discussion
 References
 
Chemicals and Biochemicals. Dithiothreitol, sucrose, 2-mercaptoethanol, glycerol, methanol, and acetone were purchased from Fisher Scientific Co. (Pittsburgh, PA). Isopropyl-1-thio-D-galactopyranoside was from AMRESCO Inc. (Solon, OH). The enantiomers of 1-naphthyl-1-ethanol and 2-naphthyl-1-ethanol were purchased from Aldrich Chemical Co. (Milwaukee, WI). Dehydroepiandrosterone (DHEA), PAP, PAPS, and PAP-agarose were obtained from Sigma-Aldrich (St. Louis, MO).

Prokaryotic Expression and Purification of Human Hydroxysteroid Sulfotransferase. For overexpression and purification, the human hydroxysteroid sulfotransferase cDNA coding region was transferred from a cDNA clone in a pKK233–2 vector (Comer et al., 1993Go) (EMBL accession number: XM_049895, kindly provided by Dr. Charles Falany at the University of Alabama at Birmingham) into a pET-3c (with a T7 promotor; Novagen, Madison, WI) vector between the NdeI restriction site and the HindIII site. The newly constructed expression vector was transformed into Escherichia coli BL21 (DE3) cells (Novagen). The bacterial cell cultures were grown from single colonies in 20 ml of Luria broth containing 50 µg/ml ampicillin. After incubation overnight at 37°C, the culture was used to inoculate 500 ml of the Luria broth medium with 1 mM isopropyl-1-thio-D-galactopyranoside. The second stage culture was incubated on a reciprocating shaker (250 rpm) overnight at 30°C. The cells were harvested by centrifugation at 10,000g for 30 min. The cell pellet, about 3.8 g (wet weight) was suspended in 25 ml of ice-cold buffer A (25 mM Tris-HCl buffer, pH 7.4, containing 0.25 M sucrose, 10% (v/v) glycerol, 1 mM phenylmethylsulfonyl fluoride, 1 µM pepstatin A, and 1 mM dithiothreitol). Cells in this suspension were then disrupted at 4°C with a Sonifier model 350 (Bronson Sonic Power Company, Danbury, CT). The sonicator was programmed to provide three sonication periods of 90 s each (using 2-s cycle pulses at 50% power output), with 30 s "off-time" between sonication periods. The supernatant fluid was collected after centrifugation at 24,000g for 30 min. Solid PEG8000 was then slowly added with stirring to the supernatant until a final concentration of 5% (w/v) was reached. The solution was stirred at 4°C for 30 min before centrifugation at 24,000g for 30 min. The pellet was discarded, and more PEG8000 was added to the supernatant fraction to reach a concentration of 40% (w/v). After stirring for 30 min at 4°C, the mixture was subjected to centrifugation at 24,000g for 30 min. The resulting pellet was dissolved in 10 ml of buffer A. This extraction and precipitation procedure was repeated two more times, and the final volume of the precipitated protein solution was 30 ml.

Chromatography on PAP-agarose was used to purify the recombinant ST2A3. The resuspended precipitate of 40% PEG8000 was charged onto a column of PAP-agarose (5 ml) that had been previously equilibrated with buffer A. The column was washed with 250 ml of buffer A, and the recombinant protein was eluted from the column with 30 ml of buffer A containing 250 µM PAP. The effluent was diluted with 10 volumes of buffer A followed by ultrafiltration (PM-10 membrane; Millipore Corporation, Bedford, MA) for three times to remove the excess PAP remaining in the enzyme solution. The final concentration of PAP in the enzyme solution was 0.3 µM. The enzyme solution was then concentrated by ultrafiltration (PM-10 membrane), and the protein concentration was determined using a modified Lowry procedure (Bensadoun and Weinstein, 1976Go), with bovine serum albumin as standard. The resulting ST2A3 was highly purified (apparent homogeneity by SDS-polyacrylamide gel electrophoresis with Coomassie blue staining). It shared similar mobility on SDS-polyacrylamide gel electrophoresis with that reported for the native hydroxysteroid sulfotransferase purified from human liver tissue (Falany et al., 1989Go). Specific activity of the purified ST2A3 (assay at pH 5.5) was 106 nmoles DHEA sulfate formed per minute per milligram of enzyme.

Assays for Catalytic Activity of ST2A3. During expression and purification, the enzymatic activity was monitored with DHEA as substrate using a methylene blue assay procedure described previously (Nose and Lipmann, 1958Go; Sheng et al., 2001Go). In addition to the ST2A3, assay mixtures contained 0.25 M sodium acetate (pH 5.5), 0.050 mM DHEA, 7.5 mM 2-mercaptoethanol, and 0.20 mM PAPS. Reactions were carried out at 37°C for 30 min.

The kinetic constants of the recombinant protein in the sulfation of the stereoisomers of 1- and 2-naphthyl-1-ethanol were determined at pH 7.0 using a published HPLC method for determination of substrate-dependent formation of PAP in the reaction (Duffel et al., 1989Go; Sheng et al., 2001Go). This procedure has proven to be especially useful for reactions resulting in the formation of benzylic sulfates such as 1- and 2-naphthyl-1-ethanol where stability of the product often limits accurate determination of the rate of sulfation. Reaction mixtures of 40 µl of total volume contained 0.25 M potassium phosphate buffer (pH 7.0), 7.5 mM 2-mercaptoethanol, 0.20 mM PAPS, and various concentrations of the substrates dissolved in acetone (the final concentration of acetone in the assay was 2.5% v/v). The reaction mixture with the same amount of acetone but no substrate added was used as control. Both control and experimental reactions were initiated by addition of enzyme, incubated at 37°C for 30 min, and terminated by addition of 40 µl of methanol. The substrate-dependent formation of PAP in the reaction was determined by HPLC. Analyses were carried out on an Econosphere C18 column (300-Å, 5 µ, 4.6 mm x 250 mm; Alltech, Deerfield, IL), with a mobile phase of water/methanol (88:12, v/v) containing 65 mM KH2PO4 (pH 5.45), 1.0 mM 1-octylamine, and 65 mM NH4Cl. A flow rate of 2 ml/min and detection at 254 nm was used for all determinations of PAP. The concentration of PAP formed in a reaction mixture was determined from the HPLC peak area using a linear standard curve relating peak area to the concentration of PAP. The limit of detection of substrate-dependent PAP formation was 0.1 nmol/min/mg. At least six concentrations of each substrate were used and these included concentrations both greater than and less than the apparent Km. Apparent Km and Vmax values were obtained by fitting the initial rate data to the folowing equation: {nu} = Vmax * [S]/(Km + [S]). The apparent Km and Vmax values are presented as the mean ± the standard error.


    Results and Discussion
 Top
 Abstract
 Materials and Methods
 Results and Discussion
 References
 
Previous kinetic studies on the rat hydroxysteroid sulfotransferase, ST2A2, showed that it stereospecifically catalyzed the sulfation of 1-naphthyl-1-ethanol (Banoglu and Duffel, 1999Go; Sheng and Duffel, 2001Go). We have now explored stereospecificity of the homologous human enzyme, ST2A3, by evaluating the R-(+)-and S-(-)-enantiomers of both 1-naphthyl-1-ethanol and 2-naphthyl-1-ethanol as model substrates. Stereospecificity was seen in the sulfation of enantiomers of 1-naphthyl-1-ethanol catalyzed by ST2A3, wherein the R-(+)-isomer was a substrate, but the S-(-)-isomer was not (Table 1). Although the S-(-)-enantiomer of 1-naphthyl-1-ethanol was not a substrate, it was still able to interact with the ST2A3 enzyme and inhibit catalytic activity toward DHEA. The specific activity of ST2A3 in the sulfation of DHEA was significantly decreased upon addition of 500 µM S-(-)-1-naphthyl-1-ethanol (Fig. 2). In contrast, stereoselectivity was not seen in the sulfation of enantiomers of 2-naphthyl-1-ethanol. Thus, the initial velocities of both R-(+)- and S-(-)-isomers were similar, and the ratio of the kcat/Km values were only slightly different (Table 1).


View this table:
[in this window]
[in a new window]
 
TABLE 1 Kinetic constants for the sulfation of naphthyl-1-ethanols catalyzed by ST2A3a

 


View larger version (30K):
[in this window]
[in a new window]
 
FIG. 2. Inhibition of the ST2A3-catalyzed sulfation of DHEA by S-(-)-1-naphthyl-1-ethanol.

All assays contained 5 µM DHEA with 0, 50, or 500 µM S-(-)-1-naphthyl-1-ethanol, as indicated, and were carried out at pH 7.0 and 37°C using the HPLC method described under Materials and Methods. Data shown are the mean ± S.E. of at least three determinations. The asterisk (*) indicates that the specific activity was significantly different from that obtained with DHEA alone (P < 0.05).

 

These results are analogous to those seen with the homologous enzyme from rat liver (Banoglu and Duffel, 1999Go), in which steric interactions between the ethanol functionality and a hydrogen atom at the peri-position (carbon 8) on the naphthyl ring system (Fig. 1) play an important role in determining substrate stereoselectivity for 1-naphthyl-1-ethanol. It has long been recognized that there are significant steric interactions between substituents on the benzylic carbon of 1-alkylsubstituted naphthalenes and the hydrogen in the C-8 position of the naphthalene ring (Balasubramaniyan, 1966Go). Moreover, other alkyl-substituted arenes also exhibit this effect (Bentley and Dewar, 1970Go).

Although it is apparent that the interaction of R-(+)-1-naphthyl-1-ethanol is catalytically productive, the exact nature of the interaction between the S-(-)-1-naphthyl-1-ethanol and the ST2A3 is not yet clear. Nonetheless, preliminary molecular docking studies (not shown) on the naphthyl-1-ethanols modeled in the sulfuryl acceptor site of the crystal structure coordinates of ST2A3 do suggest a potential explanation for further analysis. That is, the naphthyl ring of S-(-)-1-naphthyl-1-ethanol may bind to the sulfuryl acceptor site in a position similar to that occurring in the binding of R-(+)-1-naphthyl-1-ethanol and both enantiomers of 2-napthyl-1-ethanol. However, in such a case, the peri-interactions with S-(-)-1-naphthyl-1-ethanol would prevent conformational changes that would be necessary for proper alignment of the benzylic hydroxyl for catalysis to occur. As noted in previous studies (Kakuta et al., 1998Go), such alignment between the oxygen of an acceptor molecule and the sulfuryl group, as well as the assistance of a conserved histidine residue in proton abstraction, is essential for catalysis. With the 2-naphthyl-1-ethanols, there are no such peri-interactions (Fig. 1), and conformational rotation is allowed for the hydroxyl group to be in a catalytically favorable position for accepting the sulfuryl group from PAPS. Thus, the stereospecificity of ST2A3 for the R-(+)-isomer of 1-naphthyl-1-ethanol as substrate is consistent with the suggestion that a major determinant of binding orientation for these naphthyl-1-ethanols at the active site of the enzyme is the position of the naphthyl ring system.

Although the use of rodent enzymes as models for catalytic function of human enzymes is usually subject to significant interspecies differences, the observed stereochemical properties of both the rat and human sulfotransferases with these model naphthylethanols suggest that previous results on the specificity of the rat hydroxysteroid sulfotransferase for chiral benzylic alcohols (Chen et al., 1996Go; Banoglu and Duffel, 1997Go, 1999Go) may have direct relevance to the human enzyme. This may be particularly applicable to those hydroxyalkyl polycyclic aromatics where peri-interactions constrain conformational rotation. Future studies will focus on better definition of the full extent of these parallels in stereospecificity as well as the identification of specific key amino acid residues at the enzyme active sites that contribute to the stereoselectivity of both the rat and human hydroxysteroid sulfotransferases with chiral alcohols that exhibit varying degrees of conformational restriction.


Jonathan J. Sheng
Michael W. Duffel

Division of Medicinal and Natural Products Chemistry, College of Pharmacy, University of Iowa, Iowa City, Iowa


    Acknowledgments
 
We thank Dr. Charles Falany at the University of Alabama at Birmingham for providing the human ST2A3 cDNA.


    Footnotes
 
This work was supported by research Grant R01 CA38683 and postdoctoral fellowship F32 CA91704 from the National Cancer Institute, National Institutes of Health.

1 Abbreviations used are: PAPS, 3'-phosphoadenosine 5'-phosphosulfate; PAP, adenosine 3',5'-diphosphate; DHEA, dehydroepiandrosterone; PEG8000, polyethylene glycol 8000; HPLC, high performance liquid chromotography; EMBL, European Molecular Biology Laboratory; ST2A3, hDHEA-ST, and SULT2A1, human hydroxysteroid sulfotransferase (EMBL accession number XM_049895; PDB code 1EFH [PDB] ); ST2A2, rat hydroxysteroid sulfotransferase (EMBL accession number M33329 [GenBank] ). Back

Address correspondence to: Michael W. Duffel, Division of Medicinal and Natural Products Chemistry, College of Pharmacy, The University of Iowa, Iowa City, IA 52242. E-mail: michael-duffel{at}uiowa.edu


    References
 Top
 Abstract
 Materials and Methods
 Results and Discussion
 References
 


Balasubramaniyan V (1966) peri Interaction in naphthalene derivatives. Chem Rev 66: 567-633.

Banoglu E and Duffel MW (1997) Studies on the interactions of chiral secondary alcohols with rat hydroxysteroid sulfotransferase STa. Drug Metab Dispos 25: 1304-1310.[Abstract/Free Full Text]

Banoglu E and Duffel MW (1999) Importance of peri-interactions on the stereospecificity of rat hydroxysteroid sulfotransferase STa with 1-arylethanols. Chem Res Toxicol 12: 278-285.[CrossRef][Medline]

Bensadoun A and Weinstein D (1976) Assay of proteins in the presence of interfering materials. Anal Biochem 70: 241-250.[CrossRef][Medline]

Bentley MD and Dewar MJS (1970) Proton nuclear magnetic resonance spectra of arylmethyl systems. J Org Chem 35: 2707-2710.

Chang HJ, Zhou M, and Lin SX (2001) Human dehydroepiandrosterone sulfotransferase: purification and characterization of a recombinant protein. J Steroid Biochem Mol Biol 77: 159-165.[CrossRef][Medline]

Chen G, Banoglu E, and Duffel MW (1996) Influence of substrate structure on the catalytic efficiency of hydroxysteroid sulfotransferase STa in the sulfation of alcohols. Chem Res Toxicol 9: 67-74.[CrossRef][Medline]

Comer KA, Falany JL, and Falany CN (1993) Cloning and expression of human liver dehydroepiandrosterone sulphotransferase. Biochem J 289: 233-240.

Duffel MW (1997) Sulfotransferases, in Comprehensive Toxicology Volume 3, Biotransformation (Guengerich FP ed) pp 365-383, Elsevier, Oxford.

Duffel MW, Binder TP, and Rao SI (1989) Assay of purified aryl sulfotransferase suitable for reactions yielding unstable sulfuric acid esters. Anal Biochem 183: 320-324.[CrossRef][Medline]

Duffel MW, Marshall AD, McPhie P, Sharma V, and Jakoby WB (2001) Enzymatic aspects of the phenol (aryl) sulfotransferases. Drug Metab Rev 33: 369-395.[CrossRef][Medline]

Falany CN (1997) Enzymology of human cytosolic sulfotransferases. FASEB J 11: 206-216.[Abstract]

Falany CN, Vazquez ME, and Kalb JM (1989) Purification and characterization of human liver dehydroepiandrosterone sulphotransferase. Biochem J 260: 641-646.[Medline]

Falany CN, Wheeler J, Oh TS, and Falany JL (1994) Steroid sulfation by expressed human cytosolic sulfotransferases. J Steroid Biochem Mol Biol 48: 369-375.[CrossRef][Medline]

Glatt H (1997) Sulfation and sulfotransferases 4: bioactivation of mutagens via sulfation. FASEB J 11: 314-321.[Abstract]

Glatt H, Boeing H, Engelke CE, Ma L, Kuhlow A, Pabel U, Pomplun D, Teubner W, and Meinl W (2001) Human cytosolic sulphotransferases: genetics, characteristics, toxicological aspects. Mutat Res 482: 27-40.[Medline]

Jakoby WB, Sekura RD, Lyon ES, Markus CJ, and Wang JL (1980) Sulfotransferases, in Enzymatic Basis of Detoxication (Jakoby WB ed) vol 2, pp 199-228, Academic Press, New York.

Jakoby WB and Ziegler DM (1990) The enzymes of detoxication. J Biol Chem 265: 20715-20718.[Free Full Text]

Kakuta Y, Petrotchenko EV, Pedersen LC, and Negishi M (1998) The sulfuryl transfer mechanism. Crystal structure of a vanadate complex of estrogen sulfotransferase and mutational analysis. J Biol Chem 273: 27325-27330.[Abstract/Free Full Text]

Kong ANT, Yang LD, Ma MH, Tao D, and Bjornsson TD (1992) Molecular cloning of the alcohol/hydroxysteroid form (hSTa) sulfotransferase from human liver. Biochem Biophys Res Commun 187: 448-454.[CrossRef][Medline]

Kudlacek PE, Clemens DL, Halgard CM, and Anderson RJ (1997) Characterization of recombinant human liver dehydroepiandrosterone sulfotransferase with minoxidil as the substrate. Biochem Pharmacol 53: 215-221.[Medline]

Lewis AJ, Otake Y, Walle UK, and Walle T (2000) Sulphonation of N-hydroxy-2-acetylaminofluorene by human dehydroepiandrosterone sulphotransferase. Xenobiotica 30: 253-261.[Medline]

Lyon ES and Jakoby WB (1980) The identity of alcohol sulfotransferases with hydroxysteroid sulfotransferases. Arch Biochem Biophys 202: 474-481.[CrossRef][Medline]

Lyon ES, Marcus CJ, Wang JL, and Jakoby WB (1981) Hydroxysteroid sulfotransferases. Methods Enzymol 77: 206-213.[Medline]

Miller JA and Surh Y-J (1994) Sulfonation in chemical carcinogenesis, in Handbook of Experimental Pharmacology (Kauffman FC ed) pp 429-457, Springer-Verlag, Berlin.

Nagata K and Yamazoe Y (2000) Pharmacogenetics of sulfotransferase. Ann Rev Pharmacol Toxicol 40: 159-176.[CrossRef][Medline]

Nose Y and Lipmann F (1958) Separation of steroid sulfokinases. J Biol Chem 233: 1348-1351.[Free Full Text]

Ogura K, Kajita J, Narihata H, Watabe T, Ozawa S, Nagata K, Yamazoe Y, and Kato R (1989) Cloning and sequence analysis of a rat liver cDNA encoding hydroxysteroid sulfotransferase. Biochem Biophys Res Commun 165: 168-174.[CrossRef][Medline]

Ogura K, Sohtome T, Sugiyama A, Okuda H, Hiratsuka A, and Watabe T (1990) Rat liver cytosolic hydroxysteroid sulfotransferase (sulfotransferase a) catalyzing the formation of reactive sulfate esters from carcinogenic polycyclic hydroxymethylarenes. Mol Pharmacol 37: 848-854.[Abstract]

Otterness DM and Weinshilboum R (1994) Human dehydroepiandrosterone sulfotransferase: molecular cloning of cDNA and genomic DNA. Chem-Biol Interact 92: 145-159.[Medline]

Pedersen LC, Petrotchenko EV, and Negishi M (2000) Crystal structure of SULT2A3, human hydroxysteroid sulfotransferase. FEBS Lett 475: 61-64.[CrossRef][Medline]

Rehse PH, Zhou M, and Lin SX (2002) Crystal structure of human dehydroepiandrosterone sulphotransferase in complex with substrate. [erratum appears in Biochem J 364:888]. Biochem J 364: 165-171.[Medline]

Sakakibara Y, Yanagisawa K, Takami Y, Nakayama T, Suiko M, and Liu MC (1998) Molecular cloning, expression and functional characterization of novel mouse sulfotransferases. Biochem Biophys Res Commun 247: 681-686.[CrossRef][Medline]

Sheng JJ and Duffel MW (2001) Bacterial expression, purification and characterization of rat hydroxysteroid sulfotransferase STa. Protein Expression Purif 21: 235-242.[CrossRef][Medline]

Sheng J, Sharma V, and Duffel MW (2001) Measurement of aryl and alcohol sulfotransferase activity, in Current Protocols in Toxicology, pp 4.5.1-4.5.9, John Wiley & Sons, Inc.

Shibutani S, Shaw PM, Suzuki N, Dasaradhi L, Duffel MW, and Terashima I (1998) Sulfation of alpha-hydroxytamoxifen catalyzed by human hydroxysteroid sulfotransferase results in tamoxifen-DNA adducts. Carcinogenesis 19: 2007-2011.[Abstract/Free Full Text]

Surh Y-J, Blomquist JC, Liem A, and Miller JA (1990) Metabolic activation of 9-hydroxymethyl-10-methylbenzanthracene and 1-hydroxymethylpyrene to electrophilic, mutagenic and tumorigenic sulfuric acid esters by rat hepatic sulfotransferase activity. Carcinogenesis 11: 1451-1460.[Abstract/Free Full Text]

Watabe T, Ishizuka T, Isobe M, and Ozawa N (1982) A 7-hydroxymethyl sulfate ester as an active metabolite of 7,12-dimethylbenz[a]anthracene. Science (Wash DC) 215: 403-405.[Abstract/Free Full Text]

Weinshilboum RM, Otterness DM, Aksoy IA, Wood TC, Her C, and Raftogianis RB (1997) Sulfation and sulfotransferases 1: sulfotransferase molecular biology: cDNAs and genes. FASEB J 11: 3-14.[Abstract]

Yamazoe Y, Nagata K, Yoshinari K, Fujita K, Shiraga T, and Iwasaki K (1999) Sulfotransferase catalyzing sulfation of heterocyclic amines. Cancer Lett 143: 103-107.[CrossRef][Medline]


This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
T. I. Apak and M. W. Duffel
INTERACTIONS OF THE STEREOISOMERS OF {alpha}-HYDROXYTAMOXIFEN WITH HUMAN HYDROXYSTEROID SULFOTRANSFERASE SULT2A1 AND RAT HYDROXYSTEROID SULFOTRANSFERASE STA
Drug Metab. Dispos., December 1, 2004; 32(12): 1501 - 1508.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sheng, J. J.
Right arrow Articles by Duffel, M. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sheng, J. J.
Right arrow Articles by Duffel, M. W.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition